Company Profile

Phoenix Biosystem Inc (AKA: Phoenix Bioscience Inc)
Profile last edited on: 12/12/2019      CAGE: 3MSE8      UEI: NXDUD4NDDQ93

Business Identifier: In vitro diagnostics via smartphone
Year Founded
2001
First Award
2002
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6833 Corte Munras
Pleasanton, CA 94566
   (925) 998-5075
   info@phoenixbiosystem.com
   www.phoenixbiosystem.com
Location: Single
Congr. District: 14
County: Alameda

Public Profile

Phoenix Biosystems provides assays for diabetes and alcohol monitoring. The company also develops Point-of-care (POC) diagnostic devices for disease that could be used in primary care clinics, school clinics, emergency department settings, or even at-home testing. The company's in vitro diagnostics can be deployed via smartphone.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $382,034
Project Title: HPV Point of Care Molecular Diagnostics for LMICS
2021 1 NIH $299,957
Project Title: Rapid Point of Care Molecular Diagnostics for HCV
2017 2 NIH $400,000
Project Title: Multiplexed Point of Care Nucleic Acid Assay for STI
2016 1 NIH $222,674
Project Title: Rapid Nucleic Acid Test for Chlamydia in Resource Limited Settings
2016 1 NIH $222,768
Project Title: Point of Care HIV Combo Assay

Key People / Management

  Kumar Subramanian -- CEO

  Khalid Mounzih

  Michael F Tomasco

Company News